Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
J.P. Morgan
Pharma
J&J looks to offload remaining Kenvue stake in $3.75B deal
J&J is again cutting its holdings in Kenvue. This time, it's pursuing a "debt-for-equity" offering that looks to be worth about $3.75 billion.
Eric Sagonowsky
May 13, 2024 9:04am
J.P. Morgan doubles GLP-1 market projection to $71B in 2032
Sep 11, 2023 8:55am
Vertex’s CF drug Trikafta shines but analysts bemoan pipeline
Feb 2, 2021 10:58am
Reader poll: 'Stick a fork in it'—JPM in San Francisco is done
Jan 15, 2021 12:38pm
JPM: 8 things I won't miss about the Westin St. Francis
Jan 11, 2021 12:44pm
Are the days of J.P. Morgan in San Francisco gone forever?
Jan 7, 2021 10:50am
